Development of a multiomics database for personalized prognostic forecasting in head and neck cancer: The Big Data to Decide EU Project
Despite advances in treatments, 30% to 50% of stage III-IV head and neck squamous cell carcinoma (HNSCC) patients relapse within 2 years after treatment. The Big Data to Decide (BD2Decide) project aimed to build a database for prognostic prediction modeling.